Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|July 8, 2024
Recombinant OC43 SARS-CoV-2 spike replacement virus: An improved BSL-2 proxy virus for SARS-CoV-2 neutralization assaysZhe Hu, Alberto Domingo López-Muñoz, Ivan Kosik, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Requirement for Fc effector function is overcome by binding potency for broadly reactive anti-alphavirus antibodiesVictoria Callahan, Matthew S Sutton, Christina L Gardner, et al.
Cell|November 11, 2015
Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and EgressJulie M Fox, Feng Long, Melissa A Edeling, et al.
Science Immunology|August 19, 2018
Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complementGiuseppe Lofano, Matthew J Gorman, Ashraf S Yousif, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesisJames Brett Case, Paul W Rothlauf, Rita E Chen, et al.
Nature Immunology|September 4, 2020
Publisher Correction: SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired functionEmma S Winkler, Adam L Bailey, Natasha M Kafai, et al.
Nature Immunology|August 26, 2020
SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired functionEmma S Winkler, Adam L Bailey, Natasha M Kafai, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2020
SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory functionEmma S Winkler, Adam L Bailey, Natasha M Kafai, et al.
Pageof 6